Tag: nCoV-19
Efficacy of the AstraZeneca coronavirus vaccine against the B.1.351 South African Variant
Study conclusions: A two-dose regimen of the ChAdOx1 nCoV-19 [AstraZeneca] vaccine did not show protection against mild-to-moderate Covid-19 due to the B.1.351 [South Africa ] variant. More...